K. E. Leopold

Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate

D. Kuritzkes, T. Henrich, A. Tsibris, 2010, Journal of acquired immune deficiency syndromes.

In Vivo Emergence of Vicriviroc Resistance in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Subject

Francoise F Giguel, M. Hughes, D. Kuritzkes, 2008, Journal of Virology.

ADP Ribosylation Factor 1 Activity Is Required To Recruit AP-1 to the Major Histocompatibility Complex Class I (MHC-I) Cytoplasmic Tail and Disrupt MHC-I Trafficking in HIV-1-Infected Primary T Cells

K. Collins, K. E. Leopold, D. Kulpa, 2011, Journal of Virology.

Severe Acute Kidney Injury Following Stage 1 Norwood Palliation: Effect on Outcomes and Risk of Severe Acute Kidney Injury at Subsequent Surgical Stages*

R. Ohye, D. Selewski, C. Goldberg, 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes

B. Walker, J. Hurley, D. Sherman, 2020, Proceedings of the National Academy of Sciences.

Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures

R. Paredes, D. Kuritzkes, Z. Su, 2012, Journal of Virology.

In Vivo Emergence of Vicriviroc Resistance in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Subject (cid:1) †

D. Kuritzkes, C. Flexner, Z. Su, 2008 .